These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18749266)

  • 1. Interaction between valproic Acid and phenytoin.
    Closson RG
    West J Med; 1983 Jan; 138(1):108. PubMed ID: 18749266
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
    Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
    J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased plasma protein binding of phenytoin in patients on valproic acid.
    Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
    Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effect of valproic acid on the pharmacokinetics of phenytoin.
    Lai ML; Huang JD
    Biopharm Drug Dispos; 1993 May; 14(4):365-70. PubMed ID: 8499586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid and plasma levels of phenytoin.
    Bruni J; Wilder BJ; Willmore LJ; Barbour B
    Neurology; 1979 Jun; 29(6):904-5. PubMed ID: 377134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.
    Sallustio BC; Morris RG
    Ther Drug Monit; 1992 Feb; 14(1):9-13. PubMed ID: 1546396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of valproic acid with phenytoin.
    Bruni J; Gallo JM; Lee CS; Perchalski RJ; Wilder BJ
    Neurology; 1980 Nov; 30(11):1233-6. PubMed ID: 6775245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial free and plasma valproic acid and phenytoin monitoring and drug interactions.
    Haidukewych D; Rodin EA
    Ther Drug Monit; 1981; 3(3):303-7. PubMed ID: 6798720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin.
    Dasgupta A; Crossey MJ
    Am J Med Sci; 1997 Feb; 313(2):75-9. PubMed ID: 9030671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study.
    Kuranari M; Chiba S; Ashikari Y; Kodama Y; Sakata T; Takeyama M
    J Clin Pharm Ther; 1996 Apr; 21(2):83-7. PubMed ID: 8809644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
    Dasgupta A; McLemore JL
    Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phenytoin, phenobarbital, and valproic acid, alone and in selected combinations, on schedule-controlled behavior of rats.
    Picker M; Thomas J; Koch C; Poling A
    Pharmacol Biochem Behav; 1985 Mar; 22(3):389-93. PubMed ID: 3921991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phenytoin on protein binding of valproic acid.
    Bruni J; Gallo JM; Wilder BJ
    Can J Neurol Sci; 1979 Nov; 6(4):453-4. PubMed ID: 120756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.
    Levy RH; Rettenmeier AW; Anderson GD; Wilensky AJ; Friel PN; Baillie TA; Acheampong A; Tor J; Guyot M; Loiseau P
    Clin Pharmacol Ther; 1990 Sep; 48(3):225-35. PubMed ID: 2119269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating appropriateness of digoxin, carbamazepine, valproic acid, and phenytoin usage by therapeutic drug monitoring.
    Dalaklioglu S
    Clin Lab; 2013; 59(3-4):325-31. PubMed ID: 23724621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of phenytoin clearance by valproic acid in normal subjects.
    Frigo GM; Lecchini S; Gatti G; Perucca E; Crema A
    Br J Clin Pharmacol; 1979 Dec; 8(6):553-6. PubMed ID: 391257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phenobarbital in combination with phenytoin or valproic acid on the delayed-matching-to-sample performance of pigeons.
    Karas CA; Picker M; Poling A
    Pharmacol Biochem Behav; 1986 Oct; 25(4):929-32. PubMed ID: 3097679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations.
    Dasgupta A; Wells A; Chow L
    Ther Drug Monit; 1999 Aug; 21(4):421-5. PubMed ID: 10442696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anticonvulsants on learning: performance of pigeons under a repeated acquisition procedure when exposed to phenobarbital, clonazepam, valproic acid, ethosuximide and phenytoin.
    Picker M; Poling A
    J Pharmacol Exp Ther; 1984 Aug; 230(2):307-16. PubMed ID: 6431077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.